NexgenRx Announces 2021 Year End Results with Significant Revenue Growth and $3.5m EBITDA

TORONTO, ON / ACCESSWIRE / March 25, 2022 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its annual financial results for the year ended December 31, 2021, highlighted by 12.01% revenue growth and EBITDA for the year of …